louisiana glp-1 intestinal paralysis class action Ozempic, weight-loss drugs face backlash from companies, lawyers louisiana glp-1 bowel obstruction lawyer

FDA Indications and BMI Requirements Tirzepatide is FDA approved as Mounjaro for adults with type 2 diabetes and as Zepbound for adults with chronic weight management when BMI is 30 kg/m or 27 kg/m with a weight-related condition (e.g., hypertension, dyslipidemia, T2D, OSA, CVD)

Dispose of a full sharps bin by taking it to your local pharmacy or by contacting the local council for specialist disposal

Differences between baseline and follow-up measures were analyzed using paired t -tests or Wilcoxon signed-rank tests for continuous variables and chi-squared or Fishers exact tests for categorical data

10.3390/foods14152575 46 GariboldiM